Paper96239
Neurofibromatosis and childhood leukemia.
Bader JL and 1 other. J Pediatr, 1978. Cited by 234 papers, by iCite.
Cite this record
ConductScience Library. Neurofibromatosis and childhood leukemia. Papers, record 96239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/96239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia | Major topic |
| Neurofibromatosis 1 | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Leukemia, Lymphoid | |
| Leukemia, Myeloid | |
| Leukemia, Myeloid, Acute | |
| Male | |
| Skin Diseases | |
| Xanthomatosis |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40128563 | Overt and covert genetic causes of pediatric acute lymphoblastic leukemia. | Leukemia | 2025 | https://conductscience.org/library/papers/40128563 | PubMed |
| 36684394 | ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/36684394 | PubMed |
| 35855179 | Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis. | Surg Neurol Int | 2022 | https://conductscience.org/library/papers/35855179 | PubMed |
| 34011343 | Lymphoproliferative malignancies in patients with neurofibromatosis 1. | Orphanet J Rare Dis | 2021 | https://conductscience.org/library/papers/34011343 | PubMed |
| 31657974 | Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. | Expert Rev Hematol | 2020 | https://conductscience.org/library/papers/31657974 | PubMed |
| 30724342 | Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study. | Int J Cancer | 2019 | https://conductscience.org/library/papers/30724342 | PubMed |
| 28179213 | Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients. | Turk J Haematol | 2018 | https://conductscience.org/library/papers/28179213 | PubMed |
| 26888021 | Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice. | Haematologica | 2016 | https://conductscience.org/library/papers/26888021 | PubMed |
| 26764354 | Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy. | Blood | 2016 | https://conductscience.org/library/papers/26764354 | PubMed |
| 26538735 | Chronic Myeloid Leukemia Arising in a Patient of Neurofibromatosis Type 1. | Indian J Dermatol | 2015 | https://conductscience.org/library/papers/26538735 | PubMed |
| 23018569 | Immunologic consequences of chemotherapy for acute myeloid leukemia. | J Pediatr Hematol Oncol | 2013 | https://conductscience.org/library/papers/23018569 | PubMed |
| 22240541 | Neoplasms associated with germline and somatic NF1 gene mutations. | Oncologist | 2012 | https://conductscience.org/library/papers/22240541 | PubMed |
| 21681782 | Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype. | Am J Hematol | 2011 | https://conductscience.org/library/papers/21681782 | PubMed |
| 21442270 | Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1. | Childs Nerv Syst | 2011 | https://conductscience.org/library/papers/21442270 | PubMed |
| 21266383 | Clinical features distinguish childhood chordoma associated with tuberous sclerosis complex (TSC) from chordoma in the general paediatric population. | J Med Genet | 2011 | https://conductscience.org/library/papers/21266383 | PubMed |
| 20034338 | Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations. | Paediatr Drugs | 2010 | https://conductscience.org/library/papers/20034338 | PubMed |
| 18954903 | Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. | Leuk Res | 2009 | https://conductscience.org/library/papers/18954903 | PubMed |
| 11544276 | Quantitative effects of Nf1 inactivation on in vivo hematopoiesis. | J Clin Invest | 2001 | https://conductscience.org/library/papers/11544276 | PubMed |
| 11533205 | Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia. | J Virol | 2001 | https://conductscience.org/library/papers/11533205 | PubMed |
| 10852857 | Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models. | Environ Health Perspect | 2000 | https://conductscience.org/library/papers/10852857 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/96239
GET https://conductscience.org/api/papers/v1/96239/cited_by?page=2